Device
Foresee Home
Foresee Home is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Trials by Status
active_not_recruiting125%
completed375%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruiting
ForeseeHome NRich Registry
NCT05690880
completed
Foresee Home for Monitoring Age Related Macular Degeneration (AMD)
NCT01010997
completed
Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment
NCT01083147
completed
Age-Related Macular Degeneration (AMD) - Usability Study
NCT00963339
Clinical Trials (4)
Showing 4 of 4 trials
NCT05690880
ForeseeHome NRich Registry
NCT01010997
Foresee Home for Monitoring Age Related Macular Degeneration (AMD)
NCT01083147
Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment
NCT00963339
Age-Related Macular Degeneration (AMD) - Usability Study
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4